CoraLite®594-conjugated VEGFA Polyclonal antibody CL594-19003 proteintech

$479.00
In stock
SKU
CL594-19003
Catalog No.SizePrice (USD)
CL594-19003-100UL100 μL$479.00
Catalog NumberCL594-19003
SynonymsVEGF, L-VEGF, N-VEGF, Vascular Endothelial Growth Factor, vascular endothelial growth factor A
HostRabbit
Reactivityhuman, mouse
FormLiquid
FormulationPBS, Proclin300, BSA, Glycerol
ApplicationsWB, IF/ICC, FC (Intra)
ApplicationsIF/ICC, FC (Intra)
Host / IsotypeRabbit / IgG
Tested Applications — Positive IF/ICC detected inHeLa cells
Tested Applications — Positive FC (Intra) detected inNIH/3T3 cells
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Recommended Dilutions — Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
Positive IF/ICC detected inHeLa cells
Positive FC (Intra) detected inNIH/3T3 cells
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
Tested Reactivityhuman, mouse
Cited Reactivityhuman, mouse
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag13500 Product name: Recombinant human VEGFA protein Source: e coli. -derived, PET28a Tag: 6*His Domain: 1-302 aa of BC065522 Sequence: AAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKCDKPRR Predict reactive species
Full Namevascular endothelial growth factor A
Calculated Molecular Weight412 aa, 46 kDa
GenBank Accession NumberBC065522
Gene SymbolVEGFA
Gene ID (NCBI)7422
RRIDAB_2919851
ConjugateCoraLite®594 Fluorescent Dye
Excitation/Emission Maxima Wavelengths588 nm / 604 nm
Excitation LaserYellow-Green Laser (561 nm)
Purification MethodAntigen affinity purification
UNIPROT IDP15692
Storage BufferPBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage.
FC protocol for CL594 VEGFA antibody CL594-19003Download protocol
IF protocol for CL594 VEGFA antibody CL594-19003Download protocol
human, mouseWB iScience Niclosamide suppresses gastric cancer progression through YTHDF2 inhibition-affected lactate metabolic reprogramming. Authors - Mosheng Tang View Article
Citations1
DilutionsIF/ICC : 1:50-1:500 FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationCoraLite®594

VEGFA, also named as VEGF or VPF, belongs to the PDGF/VEGF growth factor family. It is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. VEGFA induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. Defects in VEGFA are associated with microvascular complications of diabetes type 1 (MVCD1). VEGFA has 17 isoforms with MW from 16 to 45 kDa. Some isoforms have homodimer forms (e.g.; VEGFA189 38kDa or VEFGA110 34kDa). VEGF-A exists in at least seven homodimeric isoforms. The monomers consist of 121, 145, 148, 165, 183, 189, or 206 amino acids (PMID:15602010 ). This antibody can recognize all VEGFA isoforms. Protocols Product Specific Protocols FC protocol for CL594 VEGFA antibody CL594-19003 Download protocol IF protocol for CL594 VEGFA antibody CL594-19003 Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Niclosamide suppresses gastric cancer progression through YTHDF2 inhibition-affected lactate metabolic reprogramming.
    Journal: iScience | Authors: Mosheng Tang | Species: human, mouse | Application: WB

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:CoraLite®594-conjugated VEGFA Polyclonal antibody CL594-19003 proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.